Atlas Trials

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Clinical trial NCT01546142 · COMPLETED

Trial details

NCT number
NCT01546142
Sponsor
Kythera Biopharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Moderate or Severe Submental Fullness
Start date
2012-03-01
Primary completion
2013-05-01
Enrollment
516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.